Owner Boehringer Ingelheim Pharmaceuticals, Inc.

Inventors Cirillo, Pier Francesco; Hao, Ming-Hong; Ralph, Mark Stephen; Hammach, Abdelhakim; Wu, Lifen; Xiong, Zhaoming; Netherton, Russell; Goldberg, Daniel R.; Moss, Neil; Aungst, Ronald A. Jr.; Qian, Kevin Chungeng; Gao, Donghong Amy; Kamhi, Victor Marc

Agent Davies Collison Cave

Pub. Number AU-B-2004264409

PCT Pub. Number WO2005/016918

Priority 60/453,364 10.03.03 US

Filing date 2 March 2004

Wipo publication date 24 February 2005

Acceptance publication date 19 August 2010

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group